These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36598894)

  • 21. Repositioning of HIV Aspartyl Peptidase Inhibitors for Combating the Neglected Human Pathogen Trypanosoma cruzi.
    Sangenito LS; Menna-Barreto RFS; d'Avila-Levy CM; Branquinha MH; Santos ALS
    Curr Med Chem; 2019; 26(36):6590-6613. PubMed ID: 31187704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of co-infected HIV and Trypanosoma cruzi Brazilian patients.
    Da-Cruz AM; Igreja RP; Dantas W; Junqueira AC; Pacheco RS; Silva-Gonçalves AJ; Pirmez C
    Trans R Soc Trop Med Hyg; 2004 Dec; 98(12):728-33. PubMed ID: 15485703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Priming astrocytes with TNF enhances their susceptibility to Trypanosoma cruzi infection and creates a self-sustaining inflammatory milieu.
    Silva AA; Silva RR; Gibaldi D; Mariante RM; Dos Santos JB; Pereira IR; Moreira OC; Lannes-Vieira J
    J Neuroinflammation; 2017 Sep; 14(1):182. PubMed ID: 28877735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction: Severe Strongyloides stercoralis infection in kidney transplant recipients: A multicenter case-control study.
    PLOS Neglected Tropical Diseases Staff
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009342. PubMed ID: 33844681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can Triatoma virus inhibit infection of Trypanosoma cruzi (Chagas, 1909) in Triatoma infestans (Klug)? A cross infection and co-infection study.
    Marti GA; Ragone P; Balsalobre A; Ceccarelli S; Susevich ML; Diosque P; Echeverría MG; Rabinovich JE
    J Invertebr Pathol; 2017 Nov; 150():101-105. PubMed ID: 28962837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence of human immunodeficiency virus (HIV)-Trypanosoma cruzi co-infection and injectable-drugs abuse in a Buenos Aires health center].
    Dolcini G; Ambrosioni J; Andreani G; Pando MA; Martínez Peralta L; Benetucci J
    Rev Argent Microbiol; 2008; 40(3):164-6. PubMed ID: 19024504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An approach to the management of Trypanosoma cruzi infection (Chagas' disease) in immunocompromised patients.
    Martinez-Perez A; Norman FF; Monge-Maillo B; Perez-Molina JA; Lopez-Velez R
    Expert Rev Anti Infect Ther; 2014 Mar; 12(3):357-73. PubMed ID: 24484076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rat model for combined Trypanosoma cruzi and Pneumocystis carinii infection.
    Oz HS; Hughes WT; Varilek GW
    Microb Pathog; 2000 Dec; 29(6):363-5. PubMed ID: 11095921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-infection with Trypanosoma cruzi protects mice against early death by neurological or pulmonary disorders induced by Plasmodium berghei ANKA.
    Egima CM; Macedo SF; Sasso GR; Covarrubias C; Cortez M; Maeda FY; Costa FT; Yoshida N
    Malar J; 2007 Jul; 6():90. PubMed ID: 17620126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction: Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model.
    PLOS Neglected Tropical Diseases Staff
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005328. PubMed ID: 28141850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chagas' disease and HIV co-infection: genotypic characterization of the Trypanosoma cruzi strain.
    Pacheco RS; Ferreira MS; Machado MI; Brito CM; Pires MQ; Da-Cruz AM; Coutinho SG
    Mem Inst Oswaldo Cruz; 1998; 93(2):165-9. PubMed ID: 9698886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A DTU-dependent blood parasitism and a DTU-independent tissue parasitism during mixed infection of Trypanosoma cruzi in immunosuppressed mice.
    Sales-Campos H; Kappel HB; Andrade CP; Lima TP; Mattos ME; de Castilho A; Correia D; Giraldo LE; Lages-Silva E
    Parasitol Res; 2014 Jan; 113(1):375-85. PubMed ID: 24178748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trypanosoma cruzi infection in immunosuppressed mice.
    Calabrese KS; Bauer PG; Lagrange PH; Gonçalves da Costa SC
    Immunol Lett; 1992 Jan; 31(1):91-6. PubMed ID: 1532162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dirofilaria immitis and Trypanosoma cruzi natural co-infection in dogs.
    Cruz-Chan JV; Quijano-Hernandez I; Ramirez-Sierra MJ; Dumonteil E
    Vet J; 2010 Dec; 186(3):399-401. PubMed ID: 19836278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological-clinical profile and mortality in patients coinfected with Trypanosoma cruzi/HIV: experience from a Brazilian reference center.
    Hasslocher-Moreno AM; Sousa AS; Xavier SS; Mendes FSNS; Nunes EP; Grinsztejn BGJ; Mediano MFF
    Rev Soc Bras Med Trop; 2022; 55():e02402022. PubMed ID: 36287507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.
    Castro-Sesquen YE; Gilman RH; Mejia C; Clark DE; Choi J; Reimer-McAtee MJ; Castro R; Valencia-Ayala E; Flores J; Bowman N; Castillo-Neyra R; Torrico F; Liotta L; Bern C; Luchini A;
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004407. PubMed ID: 26919324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model.
    Sangenito LS; Menna-Barreto RF; D Avila-Levy CM; Santos AL; Branquinha MH
    PLoS One; 2014; 9(12):e113957. PubMed ID: 25464510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exacerbation of HIV viral load simultaneous with asymptomatic reactivation of chronic Chagas' disease.
    Sartori AM; Caiaffa-Filho HH; Bezerra RC; do S Guilherme C; Lopes MH; Shikanai-Yasuda MA
    Am J Trop Med Hyg; 2002 Nov; 67(5):521-3. PubMed ID: 12479555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.
    Sztein MB; Kierszenbaum F
    Immunology; 1992 Oct; 77(2):277-83. PubMed ID: 1427979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.